Whole blood lead levels are associated with radiographic and symptomatic knee osteoarthritis: A cross-sectional analysis in the Johnston County Osteoarthritis Project

Arthritis Research and Therapy

Volumn 13, Issue 2, 2011, Pages

  Nelson, Amanda E ^a   Shi, Xiaoyan A ^b   Schwartz, Todd A ^a,b   Chen, Jiu Chiuan ^c   Renner, Jordan B ^a   Caldwell, Kathleen L ^d   Helmick, Charles G ^d   Jordan, Joanne M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

AFRICAN AMERICAN; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; RURAL AREA; SYMPTOM; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; RADIOGRAPHY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEAD; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE;

EID: 79952094091     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3270     Document Type: Article

References (56)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F, . National Arthritis Data Workgroup Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008, 58:26-35. 10.1002/art.23176, 18163497, National Arthritis Data Workgroup.
2. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2008, 34:515-529. 10.1016/j.rdc.2008.05.007, 18687270.
3. State Statistics: State-Specific 2003, 2005, 2007 and 2009 BRFSS Prevalence Estimates. , http://www.cdc.gov/arthritis/data_statistics/state.htm
4. Moreno-Reyes R, Suetens C, Mathieu F, Begaux F, Zhu D, Rivera MT, Boelaert M, Neve J, Perlmutter N, Vanderpas J. Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 1998, 339:1112-1120. 10.1056/NEJM199810153391604, 9770558.
5. Sokoloff L. Endemic forms of osteoarthritis. Clin Rheum Dis 1985, 11:187-212.
6. Agarwal SS, Phadke SR, Fredlund V, Viljoen D, Beighton P. Mseleni and Handigodu familial osteoarthropathies: syndromic identity?. Am J Med Genet 1997, 72:435-439. 10.1002/(SICI)1096-8628(19971112)72:4<435::AID-AJMG12>3.0.CO;2-S, 9375727.
7. Barton JC, Patton MA, Edwards CQ, Griffen LM, Kushner JP, Meeks RG, Leggett RW. Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med 1994, 124:193-198.
8. Barton JC, Acton RT, Dawkins FW, Adams PC, Lovato L, Leiendecker-Foster C, McLaren CE, Reboussin DM, Speechley MR, Gordeuk VR, McLaren GD, Sholinsky P, Harris EL. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 2005, 9:231-241. 10.1089/gte.2005.9.231, 16225403.
9. Jordan JM. Arthritis in hemochromatosis or iron storage disease. Curr Opin Rheumatol 2004, 16:62-66. 10.1097/00002281-200401000-00012, 14673391.
10. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 2005, 165:2155-2161. 10.1001/archinte.165.18.2155, 16217007.
11. Centers for Disease Control and Prevention (CDC) Adult blood lead epidemiology and surveillance: United States, 2005-2007. MMWR Morb Mortal Wkly Rep 2009, 58:365-369. Centers for Disease Control and Prevention (CDC).
12. Centers for Disease Control and Prevention (CDC) Blood lead levels in young children: United States and selected states, 1996-1999. MMWR Morb Mortal Wkly Rep 2000, 49:1133-1137. Centers for Disease Control and Prevention (CDC).
13. Wittmers LE, Aufderheide AC, Wallgren J, Rapp G, Alich A. Lead in bone. IV. Distribution of lead in the human skeleton. Arch Environ Health 1988, 43:381-391. 10.1080/00039896.1988.9935855, 3196073.
14. Barry PS, Mossman DB. Lead concentrations in human tissues. Br J Ind Med 1970, 27:339-351. 1069425, 5488693.
15. Kwapuliński J, Mirosławski J, Wiechuła D, Jurkiewicz A, Tokarowski A. The femur capitulum as a biomarker of contamination due to indicating lead content in the air by participation of the other metals. Sci Total Environ 1995, 175:57-64.
16. Milachowski KA. Investigation of ischaemic necrosis of the femoral head with trace elements. Int Orthop 1988, 12:323-330. 10.1007/BF00317832, 3220625.
17. Krachler M, Domej W, Irgolic KJ. Concentrations of trace elements in osteoarthritic knee-joint effusions. Biol Trace Elem Res 2000, 75:253-263. 10.1385/BTER:75:1-3:253, 11051615.
18. Machida M, Sun SJ, Oguma E, Kayama F. High bone matrix turnover predicts blood levels of lead among perimenopausal women. Environ Res 2009, 109:880-886. 10.1016/j.envres.2009.06.005, 19595303.
19. Nie H, Sanchez BN, Wilker E, Weisskopf MG, Schwartz J, Sparrow D, Hu H. Bone lead and endogenous exposure in an environmentally exposed elderly population: the normative aging study. J Occup Environ Med 2009, 51:848-857. 10.1097/JOM.0b013e3181aa0106, 19528829.
20. Symanski E, Hertz-Picciotto I. Blood lead levels in relation to menopause, smoking, and pregnancy history. Am J Epidemiol 1995, 141:1047-1058.
21. Mushak P. New directions in the toxicokinetics of human lead exposure. Neurotoxicology 1993, 14:29-42.
22. Kosnett MJ, Becker CE, Osterloh JD, Kelly TJ, Pasta DJ. Factors influencing bone lead concentration in a suburban community assessed by noninvasixe K x-ray fluorescence. JAMA 1994, 271:197-203. 10.1001/jama.271.3.197, 8277545.
23. Berlin K, Gerhardsson L, Börjesson J, Lindh E, Lundström N, Schütz A, Skerfving S, Edling C. Lead intoxication caused by skeletal disease. Scand J Work Environ Health 1995, 21:296-300.
24. Nash D, Magder LS, Sherwin R, Rubin RJ, Silbergeld EK. Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2004, 160:901-911. 10.1093/aje/kwh296, 15496543.
25. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 2006, 114:1538-1541. 1626441, 17035139.
26. Khalil N, Wilson JW, Talbott EO, Morrow LA, Hochberg MC, Hillier TA, Muldoon SB, Cummings SR, Cauley JA. Association of blood lead concentrations with mortality in older women: a prospective cohort study. Environ Health 2009, 8:15. 10.1186/1476-069X-8-15, 2670287, 19344498.
27. Fullmer CS. Lead-calcium interactions: involvement of 1,25-dihydroxyvitamin D. Environ Res 1997, 72:45-55. 10.1006/enrs.1996.3689, 9012371.
28. Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect 1991, 91:17-32. 10.2307/3430978, 1519349, 2040247.
29. Zoeger N, Roschger P, Hofstaetter JG, Jokubonis C, Pepponi G, Falkenberg G, Fratzl P, Berzlanovich A, Osterode W, Streli C, Wobrauschek P. Lead accumulation in tidemark of articular cartilage. Osteoarthritis Cartilage 2006, 14:906-913. 10.1016/j.joca.2006.03.001, 16678451.
30. Zuscik MJ, Puzas E, O'Keefe RJ, Sheu T, Holz JD, Schwarz EM, Rosier RN, Ubayawardena R. Pb exposure regulates a complex interplay of signaling pathways in articular chondrocytes that ultimately leads to phenotypic changes resembling osteoarthritis. The Toxicologist CD - An official Journal of the Society of Toxicology 2006, 90:S1., http://www.toxicology.org/AI/FA/SOT_Toxicologist2006.pdf
31. Carmouche JJ, Puzas JE, Zhang X, Tiyapatanaputi P, Cory-Slechta DA, Gelein R, Zuscik M, Rosier RN, Boyce BF, O'Keefe RJ, Schwarz EM. Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ Health Perspect 2005, 113:749-755. 10.1289/ehp.7596, 1257601, 15929899.
32. Norman EH, Bordley WC, Hertz-Picciotto I, Newton DA. Rural-urban blood lead differences in North Carolina children. Pediatrics 1994, 94:59-64.
33. Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, Fang F, Schwartz TA, Abbate LM, Callahan LF, Kalsbeek WD, Hochberg MC. Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: The Johnston County Osteoarthritis Project. J Rheumatol 2007, 34:172-180.
34. Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum 2008, 59:1207-1213. 10.1002/art.24021, 18759314.
35. Jordan JM, Linder GF, Renner JB, Fryer JG. The impact of arthritis in rural populations. Arthritis Care Res 1995, 8:242-250. 10.1002/art.1790080407, 8605262.
36. Wang ST, Peter F. The stability of human blood lead in storage. J Anal Toxicol 1985, 9:85-88.
37. Subramanian KS. Storage and preservation of blood and urine for trace element analysis: a review. Biol Trace Elem Res 1995, 49:187-210. 10.1007/BF02788968, 8562287.
38. Jain NB, Potula V, Schwartz J, Vokonas PS, Sparrow D, Wright RO, Nie H, Hu H. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative Aging Study. Environ Health Perspect 2007, 115:871-875. 10.1289/ehp.9629, 1892138, 17589593.
39. Martin D, Glass TA, Bandeen-Roche K, Todd AC, Shi W, Schwartz BS. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol 2006, 163:467-478. 10.1093/aje/kwj060, 16421242.
40. Weisskopf MG, Jain N, Nie H, Sparrow D, Vokonas P, Schwartz J, Hu H. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. Circulation 2009, 120:1056-1064. 10.1161/CIRCULATIONAHA.108.827121, 2760410, 19738141.
41. Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS, Hu H, Woolf A. Recommendations for medical management of adult lead exposure. Environ Health Perspect 2007, 115:463-471. 10.1289/ehp.9784, 1849937, 17431500.
42. Gracia RC, Snodgrass WR. Lead toxicity and chelation therapy. Am J Health Syst Pharm 2007, 64:45-53. 10.2146/ajhp060175, 17189579.
43. Dillman RO, Crumb CK, Lidsky MJ. Lead poisoning from a gunshot wound: report of a case and review of the literature. Am J Med 1979, 66:509-514. 10.1016/0002-9343(79)91083-0, 373435.
44. DeMartini J, Wilson A, Powell JS, Powell CS. Lead arthropathy and systemic lead poisoning from an intraarticular bullet. AJR Am J Roentgenol 2001, 176:1144.
45. Helliwell TR, Kelly SA, Walsh HP, Klenerman L, Haines J, Clark R, Roberts NB. Elemental analysis of femoral bone from patients with fractured neck of femur or osteoarthrosis. Bone 1996, 18:151-157. 10.1016/8756-3282(95)00440-8, 8833209.
46. Ryan EP, Holz JD, Mulcahey M, Sheu TJ, Gasiewicz TA, Puzas JE. Environmental toxicants may modulate osteoblast differentiation by a mechanism involving the aryl hydrocarbon receptor. J Bone Miner Res 2007, 22:1571-1580. 10.1359/jbmr.070615, 17576166.
47. Charles IG, Palmer RM, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 1993, 90:11419-11423. 10.1073/pnas.90.23.11419, 47994, 7504305.
48. Mackenzie IS, Rutherford D, MacDonald TM. Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis. Arthritis Res Ther 2008, 10(Suppl 2):S3. 10.1186/ar2464, 2582806, 19007428.
49. Abramson SB. Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther 2008, 10(Suppl 2):S2. 10.1186/ar2463, 2582805, 19007427.
50. Wahl SM, Cartney-Francis N, Chan J, Dionne R, Ta L, Orenstein JM. Nitric oxide in experimental joint inflammation: benefit or detriment?. Cells Tissues Organs 2003, 174:26-33. 10.1159/000070572, 12784039.
51. Hancock CM, Riegger-Krugh C. Modulation of pain in osteoarthritis: the role of nitric oxide. Clin J Pain 2008, 24:353-365. 10.1097/AJP.0b013e31815e5418, 18427234.
52. Vaziri ND, Khan M. Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension. Clin Exp Pharmacol Physiol 2007, 34:920-925. 10.1111/j.1440-1681.2007.04644.x, 17645641.
53. Barbosa F, Sertorio JT, Gerlach RF, Tanus-Santos JE. Clinical evidence for lead-induced inhibition of nitric oxide formation. Arch Toxicol 2006, 80:811-816. 10.1007/s00204-006-0111-3, 16670857.
54. Barbosa F, Tanus-Santos JE, Gerlach RF, Parsons PJ. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 2005, 113:1669-1674. 10.1289/ehp.7917, 1314903, 16330345.
55. Sakai T. Biomarkers of lead exposure. Ind Health 2000, 38:127-142. 10.2486/indhealth.38.127, 10812836.
56. Staessen JA, Lauwerys RR, Buchet J, Bulpitt CJ, Rondia D, Vanrenterghem Y, Amery A. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 1992, 327:151-156. 10.1056/NEJM199207163270303, 1608406.